These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

194 related items for PubMed ID: 15120772

  • 21. The oral-to-intravenous equianalgesic ratio of morphine based on plasma concentrations of morphine and metabolites in advanced cancer patients receiving chronic morphine treatment.
    Takahashi M, Ohara T, Yamanaka H, Shimada A, Nakaho T, Makoto Y.
    Palliat Med; 2003 Dec; 17(8):673-8. PubMed ID: 14694918
    [Abstract] [Full Text] [Related]

  • 22. Randomized placebo-controlled trial of the activity of the morphine glucuronides.
    Penson RT, Joel SP, Bakhshi K, Clark SJ, Langford RM, Slevin ML.
    Clin Pharmacol Ther; 2000 Dec; 68(6):667-76. PubMed ID: 11180027
    [Abstract] [Full Text] [Related]

  • 23. Comparative disposition of morphine-3-glucuronide during separate intravenous infusions of morphine and morphine-3-glucuronide in sheep. Importance of the kidney.
    Milne RW, McLean CF, Mather LE, Nation RL, Runciman WB, Rutten AJ, Somogyi AA.
    Drug Metab Dispos; 1995 Mar; 23(3):334-42. PubMed ID: 7628298
    [Abstract] [Full Text] [Related]

  • 24. Morphine-6-glucuronide is responsible for the analgesic effect after morphine administration: a quantitative review of morphine, morphine-6-glucuronide, and morphine-3-glucuronide.
    Klimas R, Mikus G.
    Br J Anaesth; 2014 Dec; 113(6):935-44. PubMed ID: 24985077
    [Abstract] [Full Text] [Related]

  • 25. Pharmacokinetic modeling to predict morphine and morphine-6-glucuronide plasma concentrations in healthy young volunteers.
    Lötsch J, Skarke C, Schmidt H, Liefhold J, Geisslinger G.
    Clin Pharmacol Ther; 2002 Aug; 72(2):151-62. PubMed ID: 12189362
    [Abstract] [Full Text] [Related]

  • 26. Analgesic efficacy of morphine applied topically to painful ulcers.
    Zeppetella G, Paul J, Ribeiro MD.
    J Pain Symptom Manage; 2003 Jun; 25(6):555-8. PubMed ID: 12782436
    [Abstract] [Full Text] [Related]

  • 27. Pain-relieving properties of topically applied morphine on arterial leg ulcers: a pilot study.
    Jansen MM, van der Horst JC, van der Valk PG, Kuks PF, Zylicz Z, van Sorge AA.
    J Wound Care; 2009 Jul; 18(7):306-11. PubMed ID: 19827484
    [Abstract] [Full Text] [Related]

  • 28. An observational study examining the effects of a surgically induced inflammatory response on the distribution of morphine and its metabolites into cerebrospinal fluid.
    Wang Y, Goralski KB, Roberts DJ, Landry K, Issa ME, Sleno L, Julien LC, Wood J, Hall RI.
    Can J Anaesth; 2017 Oct; 64(10):1009-1022. PubMed ID: 28710563
    [Abstract] [Full Text] [Related]

  • 29. Treatment of painful skin ulcers with topical opioids.
    Twillman RK, Long TD, Cathers TA, Mueller DW.
    J Pain Symptom Manage; 1999 Apr; 17(4):288-92. PubMed ID: 10203881
    [Abstract] [Full Text] [Related]

  • 30. Concentrations of morphine and morphine metabolites in CSF and plasma during continuous subcutaneous morphine administration in cancer pain patients.
    Wolff T, Samuelsson H, Hedner T.
    Pain; 1996 Dec; 68(2-3):209-16. PubMed ID: 9121807
    [Abstract] [Full Text] [Related]

  • 31. Pharmacokinetics of morphine and its glucuronides after intravenous infusion of morphine and morphine-6-glucuronide in healthy volunteers.
    Lötsch J, Stockmann A, Kobal G, Brune K, Waibel R, Schmidt N, Geisslinger G.
    Clin Pharmacol Ther; 1996 Sep; 60(3):316-25. PubMed ID: 8841154
    [Abstract] [Full Text] [Related]

  • 32. Morphine analgesia in cancer pain: role of the glucuronides.
    Penson RT, Joel SP, Gloyne A, Clark S, Slevin ML.
    J Opioid Manag; 2005 Sep; 1(2):83-90. PubMed ID: 17319252
    [Abstract] [Full Text] [Related]

  • 33. Topical morphine in the treatment of painful ulcers.
    Porzio G, Aielli F, Verna L, Cannita K, Marchetti P, Ficorella C.
    J Pain Symptom Manage; 2005 Oct; 30(4):304-5. PubMed ID: 16256893
    [No Abstract] [Full Text] [Related]

  • 34. Opioids applied topically to painful cutaneous malignant ulcers in a palliative care setting.
    Zeppetella G, Porzio G, Aielli F.
    J Opioid Manag; 2007 Oct; 3(3):161-6. PubMed ID: 18027542
    [No Abstract] [Full Text] [Related]

  • 35. Pharmacokinetics of morphine-6-glucuronide following oral administration in healthy volunteers.
    Villesen HH, Kristensen K, Hansen SH, Jensen NH, Skram U, Christrup LL.
    Eur J Clin Pharmacol; 2007 Aug; 63(8):761-7. PubMed ID: 17541571
    [Abstract] [Full Text] [Related]

  • 36. Topical opioids in mice: analgesia and reversal of tolerance by a topical N-methyl-D-aspartate antagonist.
    Kolesnikov Y, Pasternak GW.
    J Pharmacol Exp Ther; 1999 Jul; 290(1):247-52. PubMed ID: 10381783
    [Abstract] [Full Text] [Related]

  • 37. Morphine-3-glucuronide inhibits morphine induced, but enhances morphine-6-glucuronide induced locomotor activity in mice.
    Handal M, Ripel A, Aasmundstad T, Skurtveit S, Mørland J.
    Pharmacol Biochem Behav; 2007 Mar; 86(3):576-86. PubMed ID: 17343905
    [Abstract] [Full Text] [Related]

  • 38. Pharmacokinetic modeling of M6G formation after oral administration of morphine in healthy volunteers.
    Lötsch J, Weiss M, Ahne G, Kobal G, Geisslinger G.
    Anesthesiology; 1999 Apr; 90(4):1026-38. PubMed ID: 10201674
    [Abstract] [Full Text] [Related]

  • 39. Pharmacokinetics of morphine and plasma concentrations of morphine-6-glucuronide following morphine administration to dogs.
    KuKanich B, Lascelles BD, Papich MG.
    J Vet Pharmacol Ther; 2005 Aug; 28(4):371-6. PubMed ID: 16050817
    [Abstract] [Full Text] [Related]

  • 40. Contribution of morphine-6-glucuronide to antinociception following intravenous administration of morphine to healthy volunteers.
    Murthy BR, Pollack GM, Brouwer KL.
    J Clin Pharmacol; 2002 May; 42(5):569-76. PubMed ID: 12017351
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.